The pharmaceutical company is being accused of infringing a patent held by a British charitable trust for its rheumatoid arthritis drug . This drug was forecasted to cross $ 2 billion mark for its annual sales as it is widely used to treat inflammation in rheumatoid arthritis and Crohn’s disease.

Cimzia is the brand name for Certolizumab. It reduces inflammation in the body. It is used for treatment of the symptoms of Crohn’s disease. It is also used for treatment of moderate-to-severe rheumatoid arthritis in adults. It is also used for other purposes. It was approved by in April 2008.

Previous ArticleFDA Announces Black Box Label Warning for Cimzia Next ArticleRemicade: Medical Uses and Drug Facts
Verdicts and Settlements
Contact Us

Subscribe Now!

[contact-form-7 404 "Not Found"]

Follow Us!

Unsafe Drugs has numerous resources on drug side effects,nutritional supplements, vitamins, and health products.

Site best viewed in Google Chrome, Firefox, Opera, Safari, IE browsers